Lifespan Cancer Institute — Providence, Rhode Island

Lifespan Cancer Institute is a clinical research site located in Providence, Rhode Island, United States 02905.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Lifespan Cancer Institute has participated in 30 clinical trials with 19 currently active.

Therapeutic areas: B-cell Non-Hodgkin Lymphoma, Metastatic Castration-resistant Prostate Cancer, Non-Hodgkin Lymphoma, Follicular Lymphoma.

Sponsors: Hoffmann-La Roche, Brown University, Eikon Therapeutics.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lifespan Cancer Institute?

Lifespan Cancer Institute has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lifespan Cancer Institute conducted?

Lifespan Cancer Institute has 30 clinical trials on record, with 19 currently active. Their work covers B-cell Non-Hodgkin Lymphoma, Metastatic Castration-resistant Prostate Cancer, Non-Hodgkin Lymphoma, Follicular Lymphoma.

Is Lifespan Cancer Institute accredited by Crixeo Health?

Yes — Lifespan Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Lifespan Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.